Vivodyne, which uses AI and robots to grow human tissues in the lab for drug discovery and development, raised a $40M Series A, taking its total funding to $78M — Vivodyne, a San Francisco-based startup using lab-grown human tissues to discover and develop drugs, raised $40 million in a Series A led by Khosla Ventures.
Posted from: this blog via Microsoft Power Automate.